Nonadherence with mood stabilizers: Prevalence and predictors

Nonadherence with mood stabilizers: Prevalence and predictors
复制标题

DOI:
10.4088/jcp.v63n0502
复制
发表时间:
2002-05-01
影响因子:
5.3
通讯作者:
Pope, M
Pope, M
中科院分区:
医学2区
文献类型:
--
作者:
Scott, J;Pope, M

文献摘要

被引文献

相似文献

背景:情绪稳定剂不依从的患病率约为18%至52%。只有1%的关于情绪稳定剂的出版物解决了这个问题。本研究的目的是探讨在一个队列的个人接受长期治疗情绪stabilizers.Method:受试者接受锂的情感障碍的患病率和预测不遵守。从生化实验室数据中鉴别出卡马西平和/或丙戊酸盐。这些受试者中有98名患有重度抑郁症(N = 20)或双相情感障碍(N = 78)(DSM-IV),并同意参加结构化临床访谈,以评估他们的药物依从性及其影响因素。结果:略低于50%的受试者(46/98)承认在过去2年中存在一定程度的药物不依从性,32%(29/92)的患者在上个月仅报告部分依从性(缺失30%或更多的处方药物)。后向逐步logistic回归分析表明,部分依从受试者与依从受试者的最佳区分是更频繁的既往不依从史。否认疾病的严重性,以及更长的持续时间被规定的情绪稳定剂。结论:情绪稳定剂不遵守率高。态度和行为比药物副作用更能预测不依从性。临床医生需要定期询问依从性问题。
Background: The prevalence of nonadherence with mood stabilizers ranges from about 18% to 52%. Only 1% of publications on mood stabilizers address this issue. This Study aimed to explore the prevalence and predictors of nonadherence in a cohort of individuals with affective disorders receiving long-term treatment with mood stabilizers.Method: Subjects receiving lithium. carbamazepine, and/or valproate were identified from biochemistry laboratory data. Ninety-eight of these subjects had major depressive disorder (N = 20) or bipolar disorder (N = 78) (DSM-IV) and gave informed consent to participate in a structured clinical interview to assess their medication adherence and the factors that influenced it.Results: Just under 50% of subjects (46/98) acknowledged some degree of medication nonadherence in the previous 2 years, and 32% (29/92) reported only partial adherence in the last month (missing 30% or more of their prescribed medication). Backward stepwise logistic regression demonstrated that partially adherent subjects were best distinguished from adherent subjects by a more frequent past history of nonadherence. denial of severity of illness, and greater duration of being prescribed a mood stabilizer.Conclusion; Rates of mood stabilizer nonadherence are high. Attitudes and behaviors are better predictors of nonadherence than side effects from medication. Clinicians need to inquire routinely about problems with adherence.